Skip to content
Brick 42 Sagl
Brick 42 Sagl

Brick 42 Sagl

High potency API

Menu

Primary menu

  • What We Do
  • Who We Are
  • Contact Us
  • Research
    • BNCT
    • TRANSBORO

Category Archives: Research

Optimizing Liposomes for BNCT Cancer Treatment

Posted on April 28, 2026 by Thomas Brooks

From Promising Compound to Winning Therapeutic: The Critical Role of Process Chemistry in API Delivery The landscape of modern medicine is defined by remarkable innovation, with advanced therapies offering unprecedented hope for complex diseases. Yet, a groundbreaking active pharmaceutical ingredient Continue reading Optimizing Liposomes for BNCT Cancer Treatment→

Posted in BNCT

Optimizing Liposomes for BNCT Cancer Treatment

Posted on April 27, 2026 by Thomas Brooks

From Promising Compound to Winning Therapeutic: The Critical Role of API Delivery In the world of advanced pharmaceuticals, a groundbreaking active pharmaceutical ingredient (API) is only half the story. A molecule can show immense promise in vitro, but its journey Continue reading Optimizing Liposomes for BNCT Cancer Treatment→

Posted in BNCT

Accelerating BNCT’s Global Adoption: Regulatory and Supply Chain Keys

Posted on April 4, 2026 by Thomas Brooks

The Next Frontier in Cancer Treatment: Navigating the Hurdles of Boron Neutron Capture Therapy (BNCT) Boron Neutron Capture Therapy (BNCT) is rapidly emerging from the realm of clinical research into a powerful therapeutic option for some of the most challenging Continue reading Accelerating BNCT’s Global Adoption: Regulatory and Supply Chain Keys→

Posted in BNCT

Novel Boron Compounds for Advanced Cancer Therapy

Posted on April 4, 2026 by Thomas Brooks

The Chemistry of Precision: Why BNCT’s Success Hinges on Advanced API Development The next wave of cancer treatments promises unprecedented precision, targeting malignant cells while leaving healthy tissue untouched. Among these innovative approaches, Boron Neutron Capture Therapy (BNCT) stands out Continue reading Novel Boron Compounds for Advanced Cancer Therapy→

Posted in BNCT

Boron: Destroying Cancer from Within

Posted on April 4, 2026 by Thomas Brooks

The Renaissance of Precision Oncology: How Boron Neutron Capture Therapy is Reshaping Cancer Treatment What if we could destroy cancer cells from the inside out, leaving healthy tissue completely unharmed? For decades, this has been a central goal in oncology. Continue reading Boron: Destroying Cancer from Within→

Posted in BNCT

Lipid Nanoparticles: Expanding BNCT’s Reach to Tumors

Posted on March 23, 2026 by Thomas Brooks

Beyond the Pill: How Advanced Drug Delivery Systems Are Revolutionizing Oncology A promising active pharmaceutical ingredient (API) can demonstrate remarkable efficacy against cancer cells in a petri dish, only to fall short in clinical trials. Why does this happen? Often, Continue reading Lipid Nanoparticles: Expanding BNCT’s Reach to Tumors→

Posted in BNCT

BNCT Shows Promise for High-Grade Central Nervous System Tumors

Posted on March 23, 2026 by Thomas Brooks

Harnessing Boron Neutron Capture Therapy (BNCT) for Hard-to-Treat Cancers The field of oncology is in a constant battle against an adaptive and formidable adversary. For some of the most aggressive cancers, such as high-grade central nervous system tumors like glioblastoma, Continue reading BNCT Shows Promise for High-Grade Central Nervous System Tumors→

Posted in BNCT

Europe’s Multi-Million Euro Push for BNCT Cancer Therapy

Posted on March 23, 2026 by Thomas Brooks

From Lab to Clinic: How Strategic Funding is Unlocking the Potential of BNCT Cancer Therapy Breakthrough therapies often follow a challenging path from promising concept to patient-ready treatment. The journey is marked by scientific hurdles, complex regulatory landscapes, and significant Continue reading Europe’s Multi-Million Euro Push for BNCT Cancer Therapy→

Posted in BNCT

Japan Leads with Clinical BNCT for Cancer

Posted on March 20, 2026 by Thomas Brooks

BNCT in the Clinic: A New Era for Targeted Cancer Therapy A long-held scientific promise has become a clinical reality. In Japan, Boron Neutron Capture Therapy (BNCT) has officially transitioned from a promising experimental approach to an approved clinical treatment Continue reading Japan Leads with Clinical BNCT for Cancer→

Posted in BNCT

Targeting Brain Tumors: BNCT’s Atomic Precision

Posted on March 20, 2026 by Thomas Brooks

A New Era in Precision Oncology: Targeting CNS Tumors with Boron Neutron Capture Therapy Treating tumors within the Central Nervous System (CNS) presents one of the most formidable challenges in modern medicine. The brain, protected by the blood-brain barrier and Continue reading Targeting Brain Tumors: BNCT’s Atomic Precision→

Posted in BNCT

Post navigation

← Older posts

Primary Sidebar Widget Area

Copyright © 2026 Brick 42 Sagl. All Rights Reserved.
Theme: Catch Box by Catch Themes
Scroll Up